Johnson & Johnson
BMV:JNJ
Johnson & Johnson
BMV:JNJ
Price:
4 285
MXN
-0.9%
Market Closed
Market Cap:
Mex$531.6B
Relative Value
The Relative Value of one
JNJ
stock under the Base Case scenario is
hidden
MXN.
Compared to the current market price of 4 285 MXN,
Johnson & Johnson
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JNJ Relative Value
HIDDEN
Multiples Across Competitors
JNJ Competitors Multiples
Johnson & Johnson Competitors
Johnson & Johnson Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Johnson & Johnson
BMV:JNJ
|
585.1B MXN | 6.2 | 21.8 | 15.2 | 18.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
944.6B USD | 14.5 | 45.8 | 30.9 | 32.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
253.8B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
232.6B CHF | 5.3 | 21.4 | 13.3 | 17 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
223.4B GBP | 5.1 | 29.3 | 16.2 | 22.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
287.6B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.9 | 8 | 9.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.2B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.7B USD | 2.5 | 17.1 | 7.2 | 8.9 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
83.4B GBP | 2.5 | 14.6 | 7.4 | 10.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
